Immunocore Holdings plc ADR (NASDAQ: IMCR) open the trading on Wednesday, with great promise as it jumped 1.79% to $34.71, before settling in for the price of $34.1 at the close. Taking a more long-term approach, IMCR posted a 52-week range of $23.15-$40.71.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 20.08%. Meanwhile, its Annual Earning per share during the time was 20.08%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 67.03%. This publicly-traded company’s shares outstanding now amounts to $50.47 million, simultaneously with a float of $50.08 million. The organization now has a market capitalization sitting at $1.75 billion. At the time of writing, stock’s 50-day Moving Average stood at $35.72, while the 200-day Moving Average is $33.27.
Immunocore Holdings plc ADR (IMCR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Immunocore Holdings plc ADR’s current insider ownership accounts for 0.76%, in contrast to 97.66% institutional ownership. According to the most recent insider trade that took place on Dec 04 ’25, this organization’s HEAD OF R&D sold 31,341 shares at the rate of 40.26, making the entire transaction reach 1,261,789 in total value, affecting insider ownership by 0. Preceding that transaction, on Dec 05 ’25, Company’s HEAD OF R&D sold 572 for 40.14, making the whole transaction’s value amount to 22,960. This particular insider is now the holder of 0 in total.
Immunocore Holdings plc ADR (IMCR) Earnings and Revenue Records
Immunocore Holdings plc ADR’s EPS increase for this current 12-month fiscal period is 67.03% and is forecasted to reach -0.87 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.48% through the next 5 years, which can be compared against the 20.08% growth it accomplished over the previous five years trading on the market.
Immunocore Holdings plc ADR (NASDAQ: IMCR) Trading Performance Indicators
Let’s observe the current performance indicators for Immunocore Holdings plc ADR (IMCR). It’s Quick Ratio in the last reported quarter now stands at 5.97. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.61. Similarly, its price to free cash flow for trailing twelve months is now 612.52.
In the same vein, IMCR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.58, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.87 at the market close of one year from today.
Technical Analysis of Immunocore Holdings plc ADR (IMCR)
[Immunocore Holdings plc ADR, IMCR] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 16.24% While, its Average True Range was 37.49.
Raw Stochastic average of Immunocore Holdings plc ADR (IMCR) in the period of the previous 100 days is set at 41.22%, which indicates a major rise in contrast to 16.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.46 that was lower than 1.51 volatility it exhibited in the past 100-days period.
